ArticleNature reviews. Clinical oncology2015

Targeted therapies: Hippo effector YAP1 inhibition—towards a new therapeutic option to overcome drug resistance.

Alessia ErricoPubMed ↗Publisher ↗

No numbers read from the abstract.